Targeting endosomal NOX2 as a potential therapy to limit influenza A virus infection
Respirology
.
2019 Oct;24(10):935-936.
doi: 10.1111/resp.13629.
Epub 2019 Jun 21.
Authors
Gabriel Laghlali
1
2
,
Michelle D Tate
1
3
Affiliations
1
Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia.
2
Master de Biologie, École Normale Supérieure de Lyon, Université Claude Bernard Lyon I, Université de Lyon, Lyon, France.
3
Department of Molecular and Translational Sciences, Monash University, Melbourne, VIC, Australia.
PMID:
31225681
DOI:
10.1111/resp.13629
No abstract available
Keywords:
immunopathology; influenza virus; therapies.
Publication types
Editorial
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Animals
Influenza A virus*
Influenza, Human*
Mice
Oxidoreductases
Pandemics
Pneumonia*
Substances
Oxidoreductases